# Effectiveness of NESA in the Treatment of Cancer Survivors

> **NCT06230679** · NA · COMPLETED · sponsor: **Aníbal Báez Suárez** · enrollment: 40 (actual)

## Conditions studied

- Cancer Survivors

## Interventions

- **DEVICE:** Non-invasive Neuromodulation
- **DEVICE:** Placebo Non-invasive Neuromodulation

## Key facts

- **NCT ID:** NCT06230679
- **Lead sponsor:** Aníbal Báez Suárez
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-19
- **Primary completion:** 2025-09-19
- **Final completion:** 2025-12-19
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06230679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06230679, "Effectiveness of NESA in the Treatment of Cancer Survivors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06230679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*